Ya-Ting Chang

878 total citations · 1 hit paper
16 papers, 553 citations indexed

About

Ya-Ting Chang is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Ya-Ting Chang has authored 16 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 8 papers in Molecular Medicine and 6 papers in Epidemiology. Recurrent topics in Ya-Ting Chang's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Ya-Ting Chang is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Ya-Ting Chang collaborates with scholars based in Taiwan, Italy and Singapore. Ya-Ting Chang's co-authors include Yen‐Hsu Chen, Shang‐Yi Lin, Chau‐Chyun Sheu, Po‐Ren Hsueh, Po‐Liang Lu, Chun-Yuan Lee, Tun‐Chieh Chen, Wei‐Ru Lin, L. Kristopher Siu and Chun‐Yu Lin and has published in prestigious journals such as ACS Applied Materials & Interfaces, Frontiers in Microbiology and Diagnostic Microbiology and Infectious Disease.

In The Last Decade

Ya-Ting Chang

13 papers receiving 538 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options

2019 382 citations Chau‐Chyun Sheu, Ya-Ting Chang et al. Frontiers in Microbiology profile →

Peers

Countries citing papers authored by Ya-Ting Chang

Since Specialization

Citations

This map shows the geographic impact of Ya-Ting Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya-Ting Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya-Ting Chang more than expected).

Fields of papers citing papers by Ya-Ting Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya-Ting Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya-Ting Chang. The network helps show where Ya-Ting Chang may publish in the future.

Co-authorship network of co-authors of Ya-Ting Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Ya-Ting Chang. A scholar is included among the top collaborators of Ya-Ting Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya-Ting Chang. Ya-Ting Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Longitudinal molecular epidemiology of ceftriaxone-resistant enterobacterales in intra-abdominal and urinary tract infections: A decade-long SMART surveillance study in Taiwan (2009–2019) 2025 ·Journal of Microbiology Immunology and Infection ·(unknown), Po‐Liang Lu, Shang‐Yi Lin, Po‐Ren Hsueh, Wen‐Chien Ko, Chun-Eng Liu, Hung-Jen Tang, Fu‐Der Wang, (unknown), Shih-Ming Tsao, Mao‐Wang Ho, Ya-Ting Chang	0
2	Stenotrophomonas maltophilia : the need for randomized controlled trials to evaluate treatment options 2025 ·PubMed ·Ya-Ting Chang, (unknown), (unknown)	0
3	Management of MDR/XDR severe infections in the critically ill 2025 ·Current Opinion in Critical Care ·(unknown), Ya-Ting Chang, David Paterson	0
4	Characteristics and Prevalence of Vancomycin-variable Enterococcus faecium bacteremia in southern Taiwan 2024 ·Journal of Microbiology Immunology and Infection ·(unknown), (unknown), (unknown), Po‐Liang Lu, Chun‐Yu Lin, Yen‐Hsu Chen, Tun‐Chieh Chen, Chung‐Hao Huang, Ya-Ting Chang, Chun-Yuan Lee, (unknown), Shang‐Yi Lin	1
5	Estimating genome-wide DNA methylation heterogeneity with methylation patterns 2023 ·Epigenetics & Chromatin ·(unknown), Ya-Ting Chang, (unknown), Pao‐Yang Chen	5
6	MoS₂as an Effective Cu Diffusion Barrier with a Back-End Compatible Process 2023 ·ACS Applied Materials & Interfaces ·(unknown), Ya-Ting Chang, Yu-Ting Huang, I‐Chih Ni, Mei‐Hsin Chen, Chih‐I Wu	11
7	Correlation of Vitek 2 and Agar dilution for levofloxacin susceptibility testing and clinical outcomes of Enterobacterales bacteremia with 2019 CLSI breakpoints 2022 ·Diagnostic Microbiology and Infectious Disease ·(unknown), Ya-Ting Chang, Po‐Liang Lu, Tsung-Ying Yang, (unknown), Tun‐Chieh Chen, Jiahua Wu, Shang‐Yi Lin	3
8	Pseudomonas aeruginosa sepsis presenting as oral ecthyma gangrenosum in identical twins with Bruton tyrosine kinase gene mutation: Two case reports and review of the literature 2020 ·Journal of Microbiology Immunology and Infection ·Sheng‐Chieh Lin, Bor‐Luen Chiang, Yuarn‐Jang Lee, Ya-Ting Chang, Shiuh‐Bin Fang	3
9	Combination of Colistin and Azidothymidine Demonstrates Synergistic Activity against Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae 2020 ·Microorganisms ·Ya-Ting Chang, Tsung-Ying Yang, Po‐Liang Lu, Shang‐Yi Lin, Liang‐Chun Wang, Sheng‐Fan Wang, Ya‐Ju Hsieh, Sung‐Pin Tseng	3
10	Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options breakdown → 2019 ·Frontiers in Microbiology ·Chau‐Chyun Sheu, Ya-Ting Chang, Shang‐Yi Lin, Yen‐Hsu Chen, Po‐Ren Hsueh	382
11	<p>Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible <em>Escherichia coli</em> in Taiwan, 2012-2015</p> 2019 ·Infection and Drug Resistance ·Ya-Ting Chang, L. Kristopher Siu, Jann‐Tay Wang, Tsu‐Lan Wu, Yu‐Hui Chen, Yin-Ching Chuang, Jung‐Chung Lin, Po‐Liang Lu	25
12	Management of infections caused by extended-spectrum β–lactamase-producing Enterobacteriaceae : current evidence and future prospects 2018 ·Expert Review of Anti-infective Therapy ·Chau‐Chyun Sheu, Shang‐Yi Lin, Ya-Ting Chang, Chun-Yuan Lee, Yen‐Hsu Chen, Po‐Ren Hsueh	40
13	Arteriovenous graft infection caused by Candida glabrata: A case report and literature review 2013 ·Journal of Microbiology Immunology and Infection ·Hung‐Ling Huang, Chun‐Yu Lin, Ya-Ting Chang, Yen‐Hsu Chen, (unknown), Po‐Liang Lu	3
14	Stenotrophomonas maltophilia bloodstream infection: Comparison between community-onset and hospital-acquired infections 2012 ·Journal of Microbiology Immunology and Infection ·Ya-Ting Chang, Chun‐Yu Lin, Po‐Liang Lu, (unknown), Tun‐Chieh Chen, Chi‐Yu Chen, Deng‐Chyang Wu, Tzu-Pin Wang, Chiu-Mei Lin, Wei‐Ru Lin, Yen‐Hsu Chen	49
15	A Mucormycosis Case in a Cirrhotic Patient Successfully Treated with Posaconazole and Review of Published Literature 2012 ·Mycopathologia ·Shang‐Yi Lin, Po‐Liang Lu, Kun‐Bow Tsai, Chun‐Yu Lin, Wei‐Ru Lin, Tun‐Chieh Chen, Ya-Ting Chang, (unknown), Chi‐Yu Chen, (unknown), Yen‐Hsu Chen	13
16	Molecular Epidemiology of Ciprofloxacin-Resistant Extended-Spectrum β-Lactamase–Producing Klebsiella pneumoniae in Taiwan 2011 ·Microbial Drug Resistance ·(unknown), L. Kristopher Siu, Ling Ma, Ya-Ting Chang, Po‐Liang Lu	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact